{"id":4187,"date":"2018-06-23T11:53:52","date_gmt":"2018-06-23T11:53:52","guid":{"rendered":"http:\/\/blogs.sld.cu\/oserranob\/?p=4187"},"modified":"2018-06-23T12:57:26","modified_gmt":"2018-06-23T12:57:26","slug":"p53-media-accion-de-crispr-cas9-en-edicion-del-genoma","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2018\/06\/23\/p53-media-accion-de-crispr-cas9-en-edicion-del-genoma\/","title":{"rendered":"p53 media acci\u00f3n de CRISPR\u2013Cas9 en edici\u00f3n del genoma"},"content":{"rendered":"<p style=\"text-align: justify\"><a href=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2018\/06\/2018-06-23-p53.jpg\"><img loading=\"lazy\" class=\"alignleft wp-image-4207 size-full\" style=\"border-width: 1px;margin: 5px\" title=\"(c) Haapaniemi E et al. Nature Medicine, 2018\" src=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2018\/06\/2018-06-23-p53.jpg\" alt=\"2018 06 23 - p53\" width=\"100\" height=\"87\" \/><\/a>La inhibici\u00f3n de <a title=\"Informaci\u00f3n sobre el gen en Gene\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/7157\" target=\"_blank\">p53<\/a> podr\u00eda mejorar la eficiencia de la edici\u00f3n del genoma por medio de CRISPR\u2013Cas9. Esta interacci\u00f3n, al mismo tiempo, llama la atenci\u00f3n sobre la necesidad de monitorear la funci\u00f3n de <a title=\"Informaci\u00f3n sobre el gen en Gene\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/7157\" target=\"_blank\">p53<\/a> durante las terapias celulares, por el riesgo de da\u00f1o al ADN. Puede acceder al reporte original en Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J. <a title=\"Texto completo en ingl\u00e9s\" href=\"http:\/\/www.nature.com\/articles\/s41591-018-0049-z\" target=\"_blank\">CRISPR\u2013Cas9 genome editing induces a p53-mediated DNA damage response<\/a>. Nature Medicine 2018.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La inhibici\u00f3n de p53 podr\u00eda mejorar la eficiencia de la edici\u00f3n del genoma por medio de CRISPR\u2013Cas9. Esta interacci\u00f3n, al mismo tiempo, llama la atenci\u00f3n sobre la necesidad de monitorear la funci\u00f3n de p53 durante las terapias celulares, por el riesgo de da\u00f1o al ADN. Puede acceder al reporte original en Haapaniemi E, Botla S, [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[44,23,32],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/4187"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=4187"}],"version-history":[{"count":3,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/4187\/revisions"}],"predecessor-version":[{"id":4208,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/4187\/revisions\/4208"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=4187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=4187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=4187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}